1. Monitoring Process of the National TB Control Program (NTP) in the Philippines Anna Marie Celina G. Garfin, MD Medical Specialist IV National Center for Disease Prevention and Control Department of Health Anna Marie Celina G. Garfin, MD Medical Specialist IV National Center for Disease Prevention and Control Department of Health

2. 2 Health Care System DOH – Central Office Center for Health Development Provincial/City Health Office Rural Health Unit/ PPMD Unit* * Public or private health facility

3. 3 Responsible persons – records and reports DOH – Central Office Center for Health Development Provincial/City Health Office Rural Health Unit/PPMD Unit  Designated NTP Staff  Medical  Nurse  MT  Medical  Nurse  MT  Medical/PPMD unit administrator  Nurse  MT

4. 4 Flow of reports DOH – Central Office Center for Health Development Provincial/City Health Office Rural Health Unit/ PPMD Unit Submits quarterly reports Consolidates submitted quarterly reports per municipality, PPMD unit Consolidates submitted quarterly reports per Province, City and PPMD unit Consolidates submitted quarterly reports per region

5. 5 Reporting Forms  Quarterly report on laboratory activities  Quarterly report on case finding  Quarterly report on treatment outcome  Quarterly report on drug inventory

6. 6 Sources of Data  Quarterly report on laboratory activities –Laboratory Register  Quarterly report on case finding –TB Register  Quarterly report on treatment outcome –TB register  Quarterly report on drug inventory –Physical inventory –Stock cards

7. 7 Data gathered  Distribution of new smear-positive cases according to age and sex  Number of smear-positive cases referred by private physicians  Number of new smear-positive cases detected by PPMD units  Number of private referring physicians  Distribution of patients as to classification of TB (Pulmonary and Extra-pulmonary)  Distribution of patients as to type of TB Patients ( new, relapse, failure, RAD, trans-in, other)

8. 8 Indicators  Three sputum collection rate  Positivity rate  Proportion of pul. smear-positive cases out of total pul. cases  Case detection Rate  Case notification Rate of new smear-positive cases per 100,000 population

9. 9 Indicators  Sputum conversion rate at the end of two months of treatment for new smear-positive cases (%)  Treatment outcomes for each of new smear- positive cases, new smear-negative cases, relapse cases, and failure cases (%)  Additionality

10. 10 Who does the monitoring?  Monitoring team –Representatives from the public and private sector Department of Health – Central and Regional levels Local government unit – Provincial level Philippine Coalition Against TB Tropical Disease Foundation, Inc.

11. 11 How is monitoring done?  How data are analyzed? –Correctness, consistency, and completeness –Compare data with standard indicators –Interpret trends –Identify factors that hinders or facilitates achievement of standards –Draw recommendations

12. 12 How Feedback is done?  Right after the visit  Consultative workshops  Planning workshops

13. 13 Thank You